FIELD: chemistry.
SUBSTANCE: invention relates to a compound represented by the following general formula (I), or a pharmaceutically acceptable salt thereof, and a medicament and a pharmaceutical composition comprising the claimed compound or a pharmaceutically acceptable salt thereof, as well as to the use of the claimed compound or its pharmaceutically acceptable salt. (I). In the formula (I) dotted line indicates a single bond or double bond, Q represents an oxygen atom, a sulfur atom or NR5, and R1-R5 have the meaning given in the claims.
EFFECT: compounds can be used to treat arrhythmias.
10 cl, 2 tbl, 50 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL CYCLOHEXANE DERIVATIVE, PRODRUG AND SALT THEREOF AND DIABETES THERAPEUTIC AGENT CONTAINING SAID COMPOUNDS | 2005 |
|
RU2394015C2 |
DIAMINE DERIVATIVES | 2003 |
|
RU2333203C2 |
CYCLOALKANE DERIVATIVE | 2013 |
|
RU2635354C2 |
DISPIROPYRROLIDINE DERIVATIVES | 2012 |
|
RU2612534C2 |
PRODRUG OF THE AMINO ACID DERIVATIVE | 2017 |
|
RU2739318C2 |
MORPHOLINE TYPE CINNAMIDE DERIVATIVE | 2006 |
|
RU2381225C1 |
CONDENSED AMINOHYDROTHIAZINE DERIVATIVE | 2009 |
|
RU2476431C2 |
IMIDAZOPYRIDIN-2-ONE DERIVATIVES, HAVING mTOR INHIBITING ACTIVITY | 2009 |
|
RU2478636C2 |
BICYCLIC NITROIMIDAZOLES COVALENTLY CONNECTED TO REPLACED PHENYLOXAZOLYDINONES | 2009 |
|
RU2504547C2 |
CONDENSED QUINOLINE DERIVATIVE AND USE THEREOF | 2005 |
|
RU2384571C2 |
Authors
Dates
2018-12-28—Published
2015-02-13—Filed